ID6610 Cemiplimab for treating recurrent or metastatic cervical cancer that has progressed on or after platinum-based chemotherapy (review of TA901)

  • In development
  • GID-TA11850
  • Expected publication date: 

Documents

Documents created during the development process.

Invitation to participate